20550 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters; Glycosaminoglycans, i.e. mucopolysaccharides Heparin; Heparan
Methods, compositions, and devices for drug/live cell microarrays
#302ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
#303ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS
#304Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#305Therapeutic apoptotic cell preparations, method for producing same and uses thereof
#306Modulators of zinc activated cation channel
#307Compositions, methods and devices for forming gel implants from injected liquids
#308Mutated von Willebrand factor
#309TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH 2-O AND, OR 3-O DESULFATED HEPARINOIDS
#310Methods and compositions for treating multiple sclerosis
#311Treatment and diagnosis of ocular surface disorders
#312Methods for removing cytokines from blood with surface immobilized polysaccharides
#313Complex coacervate for controlled release and related methods
#314Isolation and Identification of Glycosaminoglycans
#315Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#316DRUG CONTAINING CATIONIZED CHITOSAN
#317Oral dissolving films
#318Method of producing heparan sulfate having anticoagulant activity
#319Heparan sulfate having high 3-O-sulfation rate in glucosamine residues
#320TREATMENT OF MYELOSUPPRESSION
#321PDGF-B /PDGF-BB binding variants of heparan sulfates
#322Combination wearable and stationary dialysis systems
#323Functional coating
#324ANTI-THROMBOGENIC GRAFTS
#325Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
#326PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS
#327OVINE ENOXAPARIN SODIUM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#328STOMATOLOGICAL COMPOSITION CONTAINING NSAID OR HEPARIN COMPOUND
#329Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
#330NOVEL DRUG DELIVERY CONJUGATED MOIETY FOR ORAL ADMINISTRATION OF DRUG UNSUITABLE FOR ORAL ADMINISTRATION AND PREPARATION METHOD THEREOF
#331THROMBIN-RESPONSIVE HYDROGELS AND DEVICES FOR AUTO-ANTICOAGULANT REGULATION
#332Medication infusion components and systems
#333PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
#334Sodium thiosulfate-containing pharmaceutical compositions
#335Methods and compositions for the prevention and treatment of disease
#336Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
#337Medical devices, systems, and methods utilizing antithrombin-heparin composition
#338Manufacture of pharmaceutical compositions
#339METHOD FOR PREVENTING TRANSPLANT FAILURE IN A HOST
#340Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same
#341Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use
#342Compositions and Methods for the Inhibition of Chondrogenesis
#343Oxidative modification improves the drugability of cell penetrating peptides as drug carriers
#344THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA
#345EXTRACELLULAR HISTONES AS BIOMARKERS FOR PROGNOSIS AND MOLECULAR TARGETS FOR THERAPY
#346Method and composition for treating cystitis
#347Anti-histone therapy in acute kidney injury
#348Roneparstat combined therapy of multiple myeloma
#349METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#350Method for production of heparin and heparan sulfate
#351COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#352PROCESS FOR THE PURIFICATION OF HEPARAN SULFATE AND USE THEREOF IN COSMETOLOGICAL AND DERMATOLOGICAL PREPARATIONS
#353COMPLEMENT INHIBITION FOR IMPROVED NERVE REGENERATION
#354PROLONGED ANTI-DIABETIC EFFECT OF FIBROBLAST GROWTH FACTOR 1 (FGF1)
#355Unit aerosol doses for anticoagulation
#356Compositions, methods and devices for forming implants from injected liquids
#357Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
#358LUMINAL VESSEL COATING FOR ARTERIOVENOUS FISTULA
#359DRUG COMPOSITION AND COATING
#360Compositions and methods for cell transplantation
#361External composition for screen foamers
#362LOCALLY RELEASED GROWTH FACTORS TO MEDIATE MOTOR RECOVERY AFTER STROKE
#363VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
#364Heparan sulphates for use in repair and/or regeneration of skin
#365PHARMACEUTICAL EXTRACTS AND USES THEREOF
#366COMPOSITIONS, USES, AND PREPARATION OF PLATELET LYSATES
#367Targeted nanoparticles
#368Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#369NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS
#370Systems and Methods for Compounding Injectable Therapeutic Agents
#371HYBRID STENT AND METHOD OF MAKING
#372Systems and methods to identify and treat subjects at risk for obstetrical complications
#373Polymeric materials including a glycosaminoglycan networked with a polyolefin-containing polymer
#374PHOSPHOLIPID DEPOT
#375Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#376Activated polyoxazolines and conjugates and compositions comprising the same
#377METHODS OF ADMINISTERING LMWH
#378Topical formulations of heparin
#379Maternal chelation for embryo, fetal and infant benefit
#380Microneedle-based transdermal delivery system and method of making same
#381Diagnostic test for early stage cancer
#382Sodium thiosulfate-containing pharmaceutical compositions
#383ANTI-HISTONE THERAPY FOR VASCULAR NECROSIS IN SEVERE GLOMERULONEPHRITIS
#384VE-CADHERIN BINDING BIOCONJUGATE
#385Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
#386COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
#387Glycosaminoglycans
#388METHODS OF TREATING TRAUMATIC BRAIN INJURY AND SEQUELAE
#389REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#390EARLY DETECTION OF PREECLAMPSIA
#391MULTIVALENT CATION FORMULATIONS OF PARTIALLY DESULFATED HEPARINS
#392SPATIOTEMPORALLY MULTICONTROLLABLE INTELIGENT DRUG-ELUTING STENT
#393Modulation of synaptic maintenance
#394METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE
#395Heparan sulphates
#396Nanospheres encapsulating bioactive material and method for formulation of nanospheres
#397Compositions and methods for cell transplantation
#398VITAMIN E-BASED NANOCARRIERS FOR DRUG DELIVERY AND METHODS OF MAKING AND USING THE SAME
#399MODULATION OF FACTOR 11 EXPRESSION
#400Carrier status of annexin A5 M2 haplotype and obstetric risks
#401Methods of bonding using evaporation operative materials having low environmental impact
#402ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS
#403Positive modulator of bone morphogenic protein-2
#404Glycosaminoglycans
#405Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation
#406Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
#407Granulysin in immunotherapy
#408Synthetic Platelets
#409PROCESS FOR THE PURIFICATION OF HEPARAN SULFATE AND USE THEREOF IN COSMETOLOGICAL AND DERMATOLOGICAL PREPARATIONS
#410Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#411Method of diagnosis, prognostic or treatment of neurodegenerative disease
#412Methods for removing cytokines from blood with surface immobilized polysaccharides
#413BIOCONJUGATES AND USES THEREOF
#414E-SELECTIN INHIBITION WORKS IN COMBINATION WITH LOW-MOLECULAR WEIGHT HEPARIN TO DECREASE VENOUS THROMBOSIS AND BLEEDING RISK
#415TRANSGENIC PRODUCTION OF HEPARIN
#416Modulation of synaptic maintenance
#417METHODS OF MANUFACTURING POLYSACCHARIDE COMPOSITIONS
#418POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS
#419Treating Bacterial Infections of the Lung
#420METHODS OF TREATING AND PREVENTING RADIATION DAMAGE
#421Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#422Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
#423ADOPTIVE CELL TRANSFER METHODS
#424POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION
#425Compositions, methods and devices for local drug delivery
#426Antimicrobial hydrochloric acid catheter lock solution and method of use
#427Biomarkers for diagnosis of transient ischemic attacks
#428Derivatives of N-desulfated glycosaminoglycans and use as drugs
#429Sodium thiosulfate-containing pharmaceutical compositions
#430Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids
#431Compositions and method for anti-sickling of red blood cells in sickle cell disease
#432HEPARAN SULPHATE
#433TREATMENT OF MYELOSUPPRESSION
#434Polymeric synthetic antidote
#435Modulation of synaptic maintenance
#436Protein biomaterials and biocoacervates and methods of making and using thereof
#437Manufacture of Pharmaceutical Compositions
#438Processes for the production of chemically-modified heparins
#439External-use composition producing foamed state upon use
#440Pharmaceutical Compositions Comprising Pyrophosphate
#441Reversible heparin molecules and methods of making and using the same
#442Methods and compositions for mobilizing stem cells
#443POLYSACCHARIDE COMPOSITIONS AND RELATED METHODS
#444Pharmaceutical composition comprising a botulinum neurotoxin and uses thereof
#445Pharmaceutical compositions comprising collagen and sodium hyaluronate
#446Prevention And/Or Treatment Of Cancer And/Or Cancer Metastasis
#447ENGINEERED MICROGELS
#448Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
#449POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION
#450Anti-thrombogenic grafts
#451Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#452Heparin-based compositions and methods for the inhibition of metastasis
#453Maternal chelation for embryo, fetal and infant benefit
#454Coacervate micro and/or nano droplets and hydrogels
#455Anti-histone therapy for vascular necrosis in severe glomerulonephritis
#456Modulation of synaptic maintenance
#457Modulation of synaptic maintenance
#458Modulation of synaptic maintenance
#459Methods for local drug delivery by microinjection array
#460STABLE COMPOSITIONS COMPRISING HEPARINOID, ACUTE-ACTING ANESTHETIC, AND BUFFER
#461Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#462Glycosaminoglycans
#463Biodegradable microbead comprising anionic polymer for improving adsorptive power to anticancer drugs, and method for preparing same
#464Polyesteramide platform for site specific drug delivery
#465Bile acid oligomer conjugate for novel vesicular transport and use thereof
#466Therapeutic apoptotic cell preparations, method for producing same and uses thereof
#467Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#468Agents for the prevention and/or treatment of central nervous system damage
#469Drug composition and coating
#470NON-COVALENT, SELF-ORGANZING HYDROGEL MATRIX FOR BIOTECHNOLOGICAL APPLICATIONS
#471Transdermal venous access locking solutions
#472Transdermal venous access locking solutions
#473Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
#474Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
#475PNEUMATIC WRAP COMPRESSION TREATMENTS FOR VENOUS CONDITIONS
#476MULTIVALENT ANTIVIRAL COMPOSITIONS, METHODS OF MAKING, AND USES THEREOF
#477Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine
#478Ocular nanoformulation and method of use in angiogenesis-mediated disorders
#479Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis
#480Lipid-polymer conjugates, their preparation and uses thereof
#481Methods and systems for inhibiting foreign-body responses in diabetic patients
#482Use of heparin and carbohydrates to treat cancer
#483Uses of antagonists of hyaluronan signaling
#484Heparin-based compositions and methods for the inhibition of metastasis
#485TREATMENT OF POSTPARTUM HAEMORRHAGE WITH CHEMICALLY MODIFIED HEPARIN OR HEPARAN SULPHATE AND A UTEROTONIC AGENT
#486High purity heparin and production method therefor
#487Self assembled films for protein and drug delivery applications
#488Cancer-related extracellular matrix signatures and related methods and products
#489AGENT FOR TREATMENT AND PREVENTION OF CANCER
#490METHOD FOR TREATMENT OF LABOR ARREST
#4917-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders
#492COMBINATION TREATMENT COMPRISING SULPHATED GLYCOSAMINOGLYCANS FOR INDUCING LABOR
#493COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR USE IN VASCULAR INTERVENTION
#494Diagnostic and Therapeutic Method
#495Low anticoagulant heparins
#496Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#497Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII
#498Granulysin in immunotherapy
#499Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
#500Polyesteramide platform for site specific drug delivery
#501Bioactive Hydrogel
#502Multi-layered structure for drug reservoir and drug eluting stent including the same
#503Use of chemically modified heparin derivates in sickle cell disease
#504Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof
#505Aqueous solution comprising a macromolecular conjugate of heparin for the treatment of blood vessels
#506Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
#507LIPID CONJUGATES IN THE TREATMENT OF CHRONIC RFHINOSINUSITIS
#508Bioactive coatings
#509Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
#510Process for the preparation of highly O-sulfated, epimerized derivatives of K5 polysacchride and intermediates therein
#511Locally released growth factors to mediate motor recovery after stroke
#512Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
#513Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#514METHODS, APPARATUS, AND COMPOUNDS FOR THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION AND OTHER CONDITIONS
#515Composition of dialysis liquid comprising crystallisation inhibitor substances
#516Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders
#517REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS
#518Methods for local drug delivery by microinjection
#519Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
#520Targeted nanoparticles
#521Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
#522Methods for removing cytokines from blood with surface immobilized polysaccharides
#523Hyaluronic acid based copolymers
#524Use of CGRP antagonist compounds for treatment of psoriasis
#525Method of increasing lean body mass
#526Methods and compositions for inhibiting cellular proliferation and surgical adhesion
#527Compositions for achieving a therapeutic effect in an anatomical structure
#528Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
#529Topical Transdermal Method for Delivering Nutrients Through the Skin for Expeditied Wound Healing and Skin Rejuvenation
#530METHOD OF MANUFACTURING COMPOSITION COMPRISING LOCAL ANESTHETIC, HEPARINOID, AND BUFFER
#531Use of antithrombin in extracorporeal membrane oxygenation
#532Method for the prevention and treatment of sepsis
#533Compositions comprising anti-CD38 antibodies and lenalidomide
#534Method of treating coronary artery disease by administering FGF-9
#535Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#536MULTI-ARM POLYETHYLENE GLYCOL DERIVATIVES, CONJUGATES AND GELS OF PHARMACEUTICALS AND THE SAME
#537Self-repairing cyclic oxide-substituted chitosan polyurethane networks
#538Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
#539Antiinfective composition
#540Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
#541Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
#542Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#543Pharmaceutical compositions with glycosaminoglycans and use thereof in the treatment of chronic ulcers
#544Compositions for achieving a therapeutic effect in an anatomical structure
#545Oligosaccharide compounds
#546Methods of promoting neuronal outgrowth by gypican 2 that binds to receptor protein tyrosine phosphatase sigma
#547VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR
#548Methods and compositions of camel derived products
#549Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments
#550Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#551Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#552Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#553KERATIN BIOMATERIALS FOR TREATMENT OF ISCHEMIA
#554Histone inhibition
#555Use of lipid conjugates in the treatment of conjunctivitis
#556Treatment of myelosuppression
#557Methods and systems for conditioning in surgery
#558Treatment of myelosuppression
#559COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
#560Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
#561Selection of medicaments that modulate the function and activity of interleukin 13
#562Heparain-bulking agent compositions and methods thereof
#563MAGNETIC NANODRUG FOR TREATING THROMBOSIS
#564Method and composition for treating cystitis
#565Polysaccharide gel formulation having increased longevity
#566Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic Targets
#567Method for Improving Vein Performance in Bypass Surgery
#568COMPOSITIONS AND METHODS FOR INHIBITION OF OR TREATMENT OF DENGUE VIRUS INFECTION
#569High purity heparin and production method therefor
#570Methods and compositions for promoting hair growth
#571Tissue targeting
#572USE OF ORAL HEPARIN PREPARATIONS TO TREAT URINARY TRACT DISEASES AND CONDITIONS
#573Immobilized biologically active entities having a high degree of biological activity
#574Method of modulating release of biomolecules having heparin-binding affinity
#575SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS AND MAJOR BLEEDINGS
#576SEMULOPARIN FOR THE PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT UNDERGOING MAJOR ORTHOPEDIC SURGERY
#577SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERY
#578Biomaterial from Wharton's jelly umbilical cord
#579Transluminal drug delivery methods and devices
#580Glycosaminoglycans
#581NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN
#582Evaporation operative materials having low environmental impact
#583Immunoactivation blood perfusion filter for the treatment of malignant tumors
#584Glycosaminoglycans
#585REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS
#586Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof
#587Hyaluronic acid based copolymers
#588Hyaluronic acid based copolymers
#589Hyaluronic acid based copolymers
#590TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#591Methods for analyzing a heparin sample
#592COMBINED USE OF PHOSPHOLIPID AND SULFATE GROUPS-CARRYING POLYSACCHARIDES FOR INHIBITING METASTATIC SPREAD
#593Modulation of synaptic maintenance
#594METHODS OF TREATMENT WITH A LOW MOLECULAR WEIGHT HEPARIN COMPOSITION
#595SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
#596PROCESSES FOR PREPARING AMINE SALTS OF KMUP-3 AND USE THEREOF
#597Phospholipid depot
#598Pharmaceutical or neutraceutical formulation
#599ANTIBACTERIAL AUXILIARY AGENT COMPRISING KOMBU EXTRACT AS ACTIVE INGREDIENT, ANTIBACTERIAL COMPOSITION, AND FOOD OR BEVERAGE
#600REMOVAL OF VIRULENCE FACTORS THROUGH EXTRACORPOREAL THERAPY